Redefining Success in Hypotony Treatment
-
By
February 10, 2026
-
10 min
Chronic ocular hypotony presents a complex challenge for ophthalmologists, often leading to irreversible damage if not addressed properly. Dr. Harry Petrushkina from Moorfields Hospital discusses innovative findings from a study on intravitreal hydroxypropylmethylcellulose (HPMC), revealing a potential method to restore vision and eye structure. By focusing on biomechanical principles and defining treatment endpoints, this approach showed significant visual improvements in patients, hinting at a new direction in managing this previously difficult condition.
1. Chronic ocular hypotony leads to risk of irreversible vision damage. 2. HPMC has shown potential in restoring eye structure and vision. 3. The first patient improved from 1/60 to 6/12 vision. 4. Measurement of axial length is crucial in managing hypotony. 5. A structured governance process is needed for new treatment approaches.
Listen Tab content
